144 related articles for article (PubMed ID: 27113547)
1. p16 and p53 expression status in head and neck squamous cell carcinoma: a correlation with histological, histoprognostic and clinical parameters.
Karpathiou G; Monaya A; Forest F; Froudarakis M; Casteillo F; Marc Dumollard J; Prades JM; Peoc'h M
Pathology; 2016 Jun; 48(4):341-8. PubMed ID: 27113547
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
Gröbe A; Hanken H; Kluwe L; Schöllchen M; Tribius S; Pohlenz P; Clauditz T; Grob T; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2013 Oct; 42(9):676-81. PubMed ID: 23721566
[TBL] [Abstract][Full Text] [Related]
4. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
[TBL] [Abstract][Full Text] [Related]
6. HPV acting on E-cadherin, p53 and p16: literature review.
Ottria L; Candotto V; Cura F; Baggi L; Arcuri C; Nardone M; Gaudio RM; Gatto R; Spadari F; Carinci F
J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):73-79. PubMed ID: 29460521
[TBL] [Abstract][Full Text] [Related]
7. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas.
Koontongkaew S; Chareonkitkajorn L; Chanvitan A; Leelakriangsak M; Amornphimoltham P
Oral Oncol; 2000 Jul; 36(4):334-9. PubMed ID: 10899671
[TBL] [Abstract][Full Text] [Related]
8. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.
Chernock RD; El-Mofty SK; Thorstad WL; Parvin CA; Lewis JS
Head Neck Pathol; 2009 Sep; 3(3):186-94. PubMed ID: 20596971
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
[TBL] [Abstract][Full Text] [Related]
10. Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection.
Cho YA; Chung JM; Ryu H; Kim EK; Cho BC; Yoon SO
Cancer Res Treat; 2019 Jul; 51(3):1052-1063. PubMed ID: 30360033
[TBL] [Abstract][Full Text] [Related]
11. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract][Full Text] [Related]
12. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
13. Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas.
Dahm V; Haitel A; Kaider A; Stanisz I; Beer A; Lill C
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1837-1843. PubMed ID: 29744637
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
[TBL] [Abstract][Full Text] [Related]
15. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
16. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression.
Mannweiler S; Sygulla S; Winter E; Regauer S
J Am Acad Dermatol; 2013 Jul; 69(1):73-81. PubMed ID: 23474228
[TBL] [Abstract][Full Text] [Related]
17. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma.
Warnakulasuriya KA; Tavassoli M; Johnson NW
J Oral Pathol Med; 1998 Sep; 27(8):376-81. PubMed ID: 9736426
[TBL] [Abstract][Full Text] [Related]
18. [Expression of six gene proteins in laryngeal carcinomas and their significance].
Wu X; He S; Wu M; Zhou L
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):648-51. PubMed ID: 16248464
[TBL] [Abstract][Full Text] [Related]
19. Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.
Broglie MA; Soltermann A; Rohrbach D; Haile SR; Pawlita M; Studer G; Huber GF; Moch H; Stoeckli SJ
Head Neck; 2013 Dec; 35(12):1698-706. PubMed ID: 23508511
[TBL] [Abstract][Full Text] [Related]
20. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]